[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.159.27. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Medical News & Perspectives
October 13, 1999

Hopes for HIV Eradication Dim as Stopping HAART Allows Resurgence

Author Affiliations
 

Not Available

Not Available

JAMA. 1999;282(14):1317-1318. doi:10.1001/jama.282.14.1317

Baltimore—A new study by researchers at the National Institute of Allergy and Infectious Diseases (NIAID) has dealt the latest in a series of blows to the hope that it might be possible to eradicate HIV in patients treated with potent combinations of drugs known as highly active antiretroviral therapy (HAART). The group's findings, reported by NIAID director Anthony J. Fauci, MD, showed that patients whose blood (and in some cases lymph nodes) had no viable HIV after they received HAART and another drug aimed at purging hidden reservoirs of latent virus experienced a swift resurgence of HIV when they discontinued therapy.

First Page Preview View Large
First page PDF preview
First page PDF preview
×